L. Kathleen Maley

L. Kathleen Maley, MBA, MS, PMP, is a highly experienced professional in the biopharmaceutical industry with a strong background in scientific leadership and project management. Currently serving as a Scientific Leadership & Research Manager at Merck since May 2016, L. Kathleen Maley manages the Investigator Initiated Studies program with a focus on Oncology, Immunology, HIV, and Women's Health, overseeing over 89 simultaneous clinical and pre-clinical studies with budgets exceeding $40 million. Previous roles include Project Manager at Sanofi, Research Scientist at Teva Pharmaceuticals, and various positions at Merck and GSK, where L. Kathleen Maley developed assays for neurodegenerative diseases and implemented regulatory compliance solutions. L. Kathleen Maley holds an MBA in Finance and Data Analytics from Drexel University, an MS in Molecular Biology from Lehigh University, and a BA in Biology from The George Washington University.